Journal of Oncology

Table of Contents: 2022

  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 5366011
  • - Research Article

Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases

Haohao Lu | Chuansheng Zheng | ... | Bin Xiong
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 9395876
  • - Research Article

Identification of Diagnostic Markers in Infantile Hemangiomas

Sicong Huang | Ruiqi Chen | ... | Hongyun Jia
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 2621969
  • - Research Article

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification

Yirizhati Aili | Nuersimanguli Maimaitiming | ... | Zengliang Wang
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 2900310
  • - Research Article

The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma

Fei Xue | Peihao Zheng | ... | Kai Hu
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 4886907
  • - Research Article

EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway

Xinyue Zhao | Jiaxi Liu | ... | Nannan Wang
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 4977600
  • - Research Article

Efficacy of Surgery in Patients with Stage I Primary Parotid Gland Lymphoma: A Population-Based Study

Xiaoyu He | Dongxu Gang | ... | Songfu Jiang
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 6001947
  • - Research Article

NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer

Gerardo I. Magallanes-Garza | Sandra K. Santuario-Facio | ... | Rocio Ortiz-Lopez
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 1590620
  • - Review Article

Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges

Rui Chen | Yan Fu | ... | Bihong T. Chen
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 3332485
  • - Research Article

Artemin Promotes the Migration and Invasion of Cervical Cancer Cells through AKT/mTORC1 Signaling

Mengjing Zhu | Ling Zhou | ... | Huaijun Zhou
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 2795939
  • - Research Article

A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma

Qi Gao | Huandi Zhou | ... | Xiaoying Xue
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 8394816
  • - Research Article

PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy

Yi-ran Zhang | Lei Zhang | ... | Yun-long Pan
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 5277440
  • - Research Article

Tumour: Fibroblast Interactions Promote Invadopodia-Mediated Migration and Invasion in Oral Squamous Cell Carcinoma

Koroku Kato | Hiroki Miyazawa | ... | Daniel W. Lambert
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 3623570
  • - Research Article

ANGPTL4 Regulates Lung Adenocarcinoma Pyroptosis and Apoptosis via NLRP3\ASC\Caspase 8 Signaling Pathway to Promote Resistance to Gefitinib

Yue Fang | Xuan Li | ... | Jiqing Hao
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 3652107
  • - Research Article

Identification of Six Diagnostic Biomarkers for Chronic Lymphocytic Leukemia Based on Machine Learning Algorithms

Yidong Zhu | Xinjin Gan | ... | Zhikang Lin
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 2515525
  • - Review Article

Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer

Hao Wu | Dianlun Qian | ... | Shibo Sun
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.